Literature DB >> 33077870

Ethnic and geographic diversity of chronic lymphocytic leukaemia.

Shenmiao Yang1, Abraham M Varghese2,3, Nitin Sood4, Carlos Chiattone5, Norah O Akinola6, Xiaojun Huang1, Robert Peter Gale7.   

Abstract

East Asians, Asian Indians and Amerindians have a five to ten-fold lower age-adjusted incidence rate (AAIR) of chronic lymphocytic leukaemia (CLL) compared with persons of predominately European descent. The data we review suggest a genetic rather than environmental basis for this discordance. All these populations arose from a common African Black ancestor but different clades have different admixture with archaic hominins including Neanderthals, Denisovans and Homo erectus, which may explain different CLL incidences. There are also some differences in clinical laboratory and molecular co-variates of CLL between these populations. Because the true age-adjusted incidence rate in African Blacks is unknown it is not possible to determine whether modern Europeans acquired susceptibility to CLL or the other populations lost susceptibility and/or developed resistance to developing CLL. We also found other B-cell lymphomas and T- and NK-cell cancers had different incidences in the populations we studied. These data provide clues to determining the cause(s) of CLL.

Entities:  

Year:  2020        PMID: 33077870     DOI: 10.1038/s41375-020-01057-5

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  45 in total

1.  Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles County.

Authors:  R P Gale; W Cozen; M T Goodman; F F Wang; L Bernstein
Journal:  Leuk Res       Date:  2000-08       Impact factor: 3.156

2.  Preservation of lower incidence of chronic lymphocytic leukemia in Chinese residents in British Columbia: a 26-year survey from 1983 to 2008.

Authors:  Vivien Mak; Dennis Ip; Oscar Mang; Chinmay Dalal; Steven Huang; Alina Gerrie; Tanya Gillan; Khaled M Ramadan; Cynthia Toze; Wing-Yan Au
Journal:  Leuk Lymphoma       Date:  2013-09-12

3.  Epidemiological patterns of leukaemia in 184 countries: a population-based study.

Authors:  Adalberto Miranda-Filho; Marion Piñeros; Jacques Ferlay; Isabelle Soerjomataram; Alain Monnereau; Freddie Bray
Journal:  Lancet Haematol       Date:  2018-01       Impact factor: 18.959

4.  Subtype-specific incidence rates of lymphoid malignancies in Hong Kong compared to the United States, 2001-2010.

Authors:  Bryan A Bassig; Wing-Yan Au; Oscar Mang; Roger Ngan; Lindsay M Morton; Dennis K M Ip; Wei Hu; Tongzhang Zheng; Wei Jie Seow; Jun Xu; Qing Lan; Nathaniel Rothman
Journal:  Cancer Epidemiol       Date:  2016-03-15       Impact factor: 2.984

Review 5.  Esophageal cancer in high-risk areas of China: research progress and challenges.

Authors:  Yingsong Lin; Yukari Totsuka; Baoen Shan; Chaochen Wang; Wenqiang Wei; Youlin Qiao; Shogo Kikuchi; Manami Inoue; Hideo Tanaka; Yutong He
Journal:  Ann Epidemiol       Date:  2016-11-25       Impact factor: 3.797

Review 6.  Epidemiology of Esophageal Squamous Cell Carcinoma.

Authors:  Christian C Abnet; Melina Arnold; Wen-Qiang Wei
Journal:  Gastroenterology       Date:  2017-08-18       Impact factor: 22.682

7.  Gradual increase of chronic lymphocytic leukemia incidence in Korea, 1999-2010: comparison to plasma cell myeloma.

Authors:  Seung Jun Lee; Hwei-Fang Tien; Hyeon Jin Park; Jung-Ah Kim; Dong Soon Lee
Journal:  Leuk Lymphoma       Date:  2015-08-28

Review 8.  The mystery of chronic lymphocytic leukemia (CLL): Why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology?

Authors:  Shen-Miao Yang; Jian-Yong Li; Robert Peter Gale; Xiao-Jun Huang
Journal:  Blood Rev       Date:  2014-12-13       Impact factor: 8.250

9.  Incidence of breast and gynaecological cancers by ethnic group in England, 2001-2007: a descriptive study.

Authors:  Megan H Shirley; Isobel Barnes; Shameq Sayeed; Alexander Finlayson; Raghib Ali
Journal:  BMC Cancer       Date:  2014-12-18       Impact factor: 4.430

10.  Differences in incidence and trends of haematological malignancies in Japan and the United States.

Authors:  Dai Chihara; Hidemi Ito; Tomohiro Matsuda; Akiko Shibata; Akira Katsumi; Shigeo Nakamura; Sobue Tomotaka; Lindsay M Morton; Dennis D Weisenburger; Keitaro Matsuo
Journal:  Br J Haematol       Date:  2013-11-18       Impact factor: 6.998

View more
  3 in total

1.  Distinct Age-Related Clinical Features and Risk Assessment in Chinese With Chronic Lymphocytic Leukemia.

Authors:  Zheng Tian; Ming Liu; Xiaosheng Fang; Xiangxiang Zhou; Peipei Li; Ying Li; Lingyan Zhang; Fang Liu; Ya Zhang; Xin Wang
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

2.  Evaluation of a Prognostic Epigenetic Classification System in Chronic Lymphocytic Leukemia Patients.

Authors:  Christina Grimm; Carmen Diana Herling; Anastasia Komnidi; Michelle Hussong; Karl-Anton Kreuzer; Michael Hallek; Michal R Schweiger
Journal:  Biomark Insights       Date:  2022-01-19

3.  Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study.

Authors:  Yang Ou; Yichen Long; Lili Ji; Yanxia Zhan; Tiankui Qiao; Xiangdong Wang; Hao Chen; Yunfeng Cheng
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.